Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.
about
Getting the balance right: Established and emerging therapies for major depressive disordersFunctional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humansAntidepressant use and risk for preeclampsia.Duloxetine in the treatment of major psychiatric and neuropathic disorders.Depression in vascular pathologies: the neurologist's point of view.Duloxetine in the management of diabetic peripheral neuropathic pain.Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescentThe Bypassing the Blues treatment protocol: stepped collaborative care for treating post-CABG depressionDuloxetine: a new selective and dual-acting antidepressant.Bipolar depression: diagnostic and treatment considerations.Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United StatesDuloxetine in the treatment of major depressive disorder.Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor.Adverse reactions to duloxetine in depression.Coanalgesics for chronic pain therapy: a narrative review.Duloxetine: a review of its use in the management of major depressive disorder in older adults.A review of the adverse effects and safety of noradrenergic antidepressants.Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels.Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.Switching to duloxetine from selective serotonin reuptake inhibitors in non- or partial responders: Results from a Spanish sample.Duloxetine in the treatment of stress urinary incontinence.Duloxetine-associated tachycardia.Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines.Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences.
P2860
Q24610225-EF42E072-3872-419F-A60D-EDBE0F8EF3D2Q24654140-D66D81CE-065F-4507-91A5-8E1143024102Q34158083-E49FC46C-DAF7-4024-A7B0-FFE2AED6C15EQ34770302-202740F2-A9DA-4B03-B6A5-08F498072DABQ35122942-D264EAA7-B60D-440F-84AD-7CD608FC99ACQ35147185-FBE01A6F-E2C5-467B-9930-E54F61193568Q35816675-C6CCCA65-E982-4558-95BE-92A1EDBFDD5FQ36069882-6F89486E-3ECF-4FC9-9C65-415092569DE7Q36407366-095DAD7D-AF60-4E4D-B150-7D1A0884F466Q36634433-5D70BCFF-8D67-4A79-A32C-EDFE3EB5BF28Q37109230-0A841612-95D5-45F7-891D-B763A684EA4FQ37125752-967DA58B-D187-45A9-A6C6-2861BCDC18F5Q37808483-AB36A19B-CA34-4D0E-9AB4-CC9EFEA5D27BQ37872294-D2D5CE38-B1B8-4963-9978-CDBE42BC5168Q37959164-7BAA8E9C-912C-437F-A47C-0E7B3EF87849Q38067355-0695F8A0-AB2D-4CDD-86FF-9D2894E27056Q38115737-7F5B7F0E-3BDF-40C5-ABAB-60283831E8FAQ39153130-0F714E4F-51F5-4B50-A215-801E393634CBQ42619331-92C07A4C-AA36-454E-9128-43B532830D21Q42665301-E5C47ABC-5FF0-487C-BDED-ACB92AC7A06DQ43267071-8F09CC08-C28D-474E-950C-0015BF0AFBE0Q46410698-A9CF5D2D-D16A-47CF-86F2-6DB2AA7C8167Q46495711-051FE4E3-B2C9-425C-82B9-721C325546E0Q51922808-F672E3EE-7DE1-4D8C-84E2-D1D4084D4C2F
P2860
Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cardiovascular profile of dulo ...... serotonin and norepinephrine.
@en
Cardiovascular profile of dulo ...... serotonin and norepinephrine.
@nl
type
label
Cardiovascular profile of dulo ...... serotonin and norepinephrine.
@en
Cardiovascular profile of dulo ...... serotonin and norepinephrine.
@nl
prefLabel
Cardiovascular profile of dulo ...... serotonin and norepinephrine.
@en
Cardiovascular profile of dulo ...... serotonin and norepinephrine.
@nl
P2093
P921
P1476
Cardiovascular profile of dulo ...... serotonin and norepinephrine.
@en
P2093
Beth A Pangallo
Craig Mallinckrodt
Curtis Wiltse
Michael E Thase
Michael J Detke
Pierre V Tran
P304
P356
10.1097/01.JCP.0000155815.44338.95
P407
P577
2005-04-01T00:00:00Z